Some GLP-1s Achieve More Weight Loss Than Others
Less than 50% of employers cover GLP-1 drugs for weight loss: JPM survey
"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated that almost 50 million adults in employer plans meet the clinical criteria for taking such drugs, which can cost thousands of dollars annually per person," according to a report from Kaiser Family Health (KFF) in October.
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Medspas are leading the charge in offering GLP-1 treatments, with 60% of medspas in the U.S. now providing these services, compared to 35% of aesthetic physician offices. Average spend per patient ...
Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...
While GLP-1 medications like Ozempic and Wegovy have garnered significant attention, bariatric surgery continues to ...
Most weight loss drugs were meant to be administered as treatment for those with Type 2 Diabetes Mellitus (T2DM), and weight ...
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
GLP-1 drugs spiked in popularity and price over the past few years, leaving the door open for illegal pharmacies to try and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback